Silvant Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $102K | Hold |
347
| – | – | ﹤0.01% | 231 |
|
|
2025
Q4 | $94.8K | Hold |
347
| – | – | ﹤0.01% | 225 |
|
|
2025
Q3 | $93.8K | Hold |
347
| – | – | ﹤0.01% | 232 |
|
|
2025
Q2 | $95.6K | Hold |
347
| – | – | ﹤0.01% | 223 |
|
|
2025
Q1 | $92.1K | Sell |
347
-7,093
| -95% | -$1.75M | ﹤0.01% | 226 |
|
|
2024
Q4 | $1.73M | Sell |
7,440
-1,146
| -13% | -$264K | 0.07% | 130 |
|
|
2024
Q3 | $1.89M | Sell |
8,586
-1,028
| -11% | -$213K | 0.08% | 122 |
|
|
2024
Q2 | $1.89M | Hold |
9,614
| – | – | 0.08% | 124 |
|
|
2024
Q1 | $2.07M | Hold |
9,614
| – | – | 0.1% | 117 |
|
|
2023
Q4 | $2.08M | Sell |
9,614
-31
| -0.3% | -$6.61K | 0.11% | 110 |
|
|
2023
Q3 | $1.93M | Hold |
9,645
| – | – | 0.12% | 110 |
|
|
2023
Q2 | $1.79M | Sell |
9,645
-4
| -0% | -$739 | 0.1% | 118 |
|
|
2023
Q1 | $1.85M | Hold |
9,649
| – | – | 0.12% | 111 |
|
|
2022
Q4 | $1.67M | Sell |
9,649
-33
| -0.3% | -$5.74K | 0.12% | 114 |
|
|
2022
Q3 | $1.72M | Sell |
9,682
-75
| -0.8% | -$14.8K | 0.12% | 112 |
|
|
2022
Q2 | $2M | Sell |
9,757
-157
| -2% | -$33.3K | 0.48% | 51 |
|
|
2022
Q1 | $2.36M | Sell |
9,914
-1,578
| -14% | -$371K | 0.45% | 53 |
|
|
2021
Q4 | $2.66M | Sell |
11,492
-578
| -5% | -$127K | 0.46% | 54 |
|
|
2021
Q3 | $2.33M | Sell |
12,070
-1,312
| -10% | -$266K | 0.42% | 63 |
|
|
2021
Q2 | $2.85M | Sell |
13,382
-428
| -3% | -$90.4K | 0.45% | 55 |
|
|
2021
Q1 | $2.82M | Hold |
13,810
| – | – | 0.48% | 54 |
|
|
2020
Q4 | $2.55M | Sell |
13,810
-3,433
| -20% | -$584K | 0.44% | 62 |
|
|
2020
Q3 | $2.88M | Sell |
17,243
-296
| -2% | -$49.9K | 0.54% | 47 |
|
|
2020
Q2 | $2.85M | Hold |
17,539
| – | – | 0.51% | 45 |
|
|
2020
Q1 | $3.03M | Sell |
17,539
-1,624
| -8% | -$323K | 0.66% | 38 |
|
|
2019
Q4 | $3.89M | Sell |
19,163
-107
| -0.6% | -$22K | 0.71% | 36 |
|
|
2019
Q3 | $4.07M | Sell |
19,270
-76
| -0.4% | -$15.9K | 0.8% | 33 |
|
|
2019
Q2 | $3.75M | Sell |
19,346
-165
| -0.8% | -$30.4K | 0.67% | 43 |
|
|
2019
Q1 | $3.21M | Sell |
19,511
-115
| -0.6% | -$20.3K | 0.58% | 53 |
|
|
2018
Q4 | $3.73M | Sell |
19,626
-23,085
| -54% | -$4.26M | 0.74% | 41 |
|
|
2018
Q3 | $7.27M | Sell |
42,711
-292
| -0.7% | -$49.2K | 0.9% | 32 |
|
|
2018
Q2 | $7.05M | Sell |
43,003
-168
| -0.4% | -$27.4K | 0.87% | 31 |
|
|
2018
Q1 | $6.98M | Buy |
+43,171
| New | +$6.87M | 0.9% | 29 |
|
Other funds holding CME
VCM
VPM
Silvant Capital Management's CME Position: Q1 2026 in Review
Silvant Capital Management held its CME Group (CME) position steady in Q1 2026 at 347 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #231.
Silvant Capital Management first reported a position in CME in Q1 2018 and has held it in 33 quarters since. The position peaked at $7.27M in Q3 2018. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Silvant Capital Management held 347 shares of CME Group worth $102K as of Q1 2026.
- Silvant Capital Management left its CME Group share count unchanged in Q1 2026.
- CME Group made up ﹤0.01% of Silvant Capital Management's portfolio in Q1 2026, its #231 holding.
- Silvant Capital Management first reported a position in CME Group in Q1 2018 and has held it in 33 quarters since.
- Silvant Capital Management's CME Group position peaked at $7.27M in Q3 2018.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Silvant Capital Management's 13F filing for Q1 2026, filed 14 May 2026.